These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The hormonal profile of hypophysial adenomas demonstrates the existence of the secretory interdependence of the pituitary cells. Fonseca ME, Morán C, Zárate A, Loyo M. Arch Invest Med (Mex); 1984 Jun; 15(4):317-30. PubMed ID: 6100161 [No Abstract] [Full Text] [Related]
23. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Kwekkeboom DJ, de Jong FH, Lamberts SW. J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356 [Abstract] [Full Text] [Related]
24. Luteinizing hormone- and alpha-subunit-secreting pituitary tumor: positive feedback of estrogen. Peterson RE, Kourides IA, Horwith M, Vaughan ED, Saxena BB, Fraser RA. J Clin Endocrinol Metab; 1981 Apr; 52(4):692-8. PubMed ID: 6782117 [No Abstract] [Full Text] [Related]
25. Value of luteinizing hormone-releasing hormone testing in bromocriptine treatment of amenorrhea and hyperprolactinemia in patients with pituitary tumors. Lamberts SW, Docter R, De Jong FH, Birkenhäger JC, Kwa HG. Fertil Steril; 1978 Mar; 29(3):287-90. PubMed ID: 346383 [Abstract] [Full Text] [Related]
26. Presence of several molecular forms of gonadotropins in pituitary adenomas. Fonseca ME, Mason M, Miranda R, Tapia R, Zárate A. Arch Invest Med (Mex); 1986 Mar; 17(2):127-34. PubMed ID: 3109342 [No Abstract] [Full Text] [Related]
27. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea. Nicoletti I, Ambrosi F, Giammartino C, Fedeli L, Mannarelli C, Filipponi P. Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473 [Abstract] [Full Text] [Related]
28. [Prolactin-secreting adenomas in males. Study of the hypophyseal-gonadal axis]. Peillon F, Bard H, Mowszowicz I, Cesselin F, Lagoguey M, Boyet F. Ann Endocrinol (Paris); 1979 Jul; 40(1):73-4. PubMed ID: 443743 [Abstract] [Full Text] [Related]
29. Follicle-stimulating hormone-secreting pituitary adenomas. Beckers A, Stevenaert A, Mashiter K, Hennen G. J Clin Endocrinol Metab; 1985 Sep; 61(3):525-8. PubMed ID: 2991325 [Abstract] [Full Text] [Related]
30. Cure of hypogonadism after removal of prolactin-secreting adenomas in men. Arafah BM, Manni A, Brodkey JS, Kaufman B, Velasco M, Pearson OH. J Clin Endocrinol Metab; 1981 Jan; 52(1):91-4. PubMed ID: 6778895 [No Abstract] [Full Text] [Related]
31. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. Daneshdoost L, Pavlou SN, Molitch ME, Gennarelli TA, Savino PJ, Sergott RC, Bosley TM, River JE, Vale WW, Snyder PJ. J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048 [Abstract] [Full Text] [Related]
32. Pathology of pituitary adenomas. Kovacs K, Horvath E. Bull Los Angeles Neurol Soc; 1977 Jul; 42(3-4):92-110. PubMed ID: 227505 [Abstract] [Full Text] [Related]
33. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy. Klibanski A, Beitins IZ, Merriam GR, McArthur JW, Zervas NT, Ridgway EC. J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260 [Abstract] [Full Text] [Related]
34. The significance of alpha-subunit as a tumor marker for gonadotropin-producing pituitary adenomas. Demura R, Jibiki K, Kubo O, Odagiri E, Demura H, Kitamura K, Shizume K. J Clin Endocrinol Metab; 1986 Sep; 63(3):564-9. PubMed ID: 2426298 [Abstract] [Full Text] [Related]
35. [Hyperprolactinemia in relation to galactorrhea and amenorrhea]. Zhang LZ. Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):218-21. PubMed ID: 6426895 [No Abstract] [Full Text] [Related]
36. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors. Kletzky OA, Davajan V, Mishell DR, Nicoloff JT, Mims R, March CM, Nakamura RM. J Clin Endocrinol Metab; 1977 Oct; 45(4):631-40. PubMed ID: 410820 [No Abstract] [Full Text] [Related]
37. Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas. Chanson P, Pantel J, Young J, Couzinet B, Bidart JM, Schaison G. J Clin Endocrinol Metab; 1997 May; 82(5):1397-402. PubMed ID: 9141523 [Abstract] [Full Text] [Related]
38. Prolactin response to sulpiride in hypogonadotropic, normogonadotropic, and hypergonadotropic primary amenorrhea. Batrinos ML, Anapliotou M, Panitsafaflia C, Pitoulis S. J Clin Endocrinol Metab; 1981 Aug; 53(2):324-30. PubMed ID: 6788792 [No Abstract] [Full Text] [Related]
39. Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man. Isaac R, Merceron R, Caillens G, Raymond JP, Ardaillou R. J Clin Endocrinol Metab; 1980 Jun; 50(6):1011-5. PubMed ID: 6768762 [Abstract] [Full Text] [Related]
40. Cushing's disease presenting as pubertal arrest. Zadik Z, Cooper M, Chen M, Stern N. J Pediatr Endocrinol; 1993 Jun; 6(2):201-4. PubMed ID: 8348226 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]